| 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of FBXO9 mRNA | CTD | PMID:21983209 |
| 1-chloro-2,4-dinitrobenzene | decreases expression | ISO | RGD:1321245 | 6480464 | Dinitrochlorobenzene results in decreased expression of FBXO9 mRNA | CTD | PMID:17374397 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1321246 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBXO9 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1321246 | 6480464 | Ethinyl Estradiol results in increased expression of FBXO9 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1321246 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBXO9 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FBXO9 mRNA | CTD | PMID:21724226 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1321246 | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO9 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1321246 | 6480464 | [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of FBXO9 mRNA | CTD | PMID:19465110 |
| 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | ISO | RGD:1321245 | 6480464 | Oxazolone results in decreased expression of FBXO9 mRNA | CTD | PMID:17374397 |
| aflatoxin B1 | increases expression | ISO | RGD:1321246 | 6480464 | Aflatoxin B1 results in increased expression of FBXO9 mRNA | CTD | PMID:19770486 |
| all-trans-retinoic acid | increases expression | ISO | RGD:1321245 | 6480464 | Tretinoin results in increased expression of FBXO9 mRNA | CTD | PMID:21934132 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1321246 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of FBXO9 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1321246 | 6480464 | Benzo(a)pyrene results in decreased expression of FBXO9 mRNA | CTD | PMID:22228805 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1321246 | 6480464 | Diethylhexyl Phthalate results in increased expression of FBXO9 mRNA | CTD | PMID:21318169 |
| bisphenol A | increases methylation | ISO | RGD:1321245 | 6480464 | bisphenol A results in increased methylation of FBXO9 gene | CTD | PMID:22576693 |
| bisphenol A | decreases expression | ISO | RGD:1321245 | 6480464 | bisphenol A results in decreased expression of FBXO9 mRNA | CTD | PMID:22576693 |
| choline | multiple interactions | ISO | RGD:1321246 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of FBXO9 mRNA; more ... | CTD | PMID:20938992 |
| cisplatin | multiple interactions | ISO | RGD:1321245 | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in increased expression of FBXO9 mRNA] | CTD | PMID:21858171 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FBXO9 mRNA | CTD | PMID:17602206 |
| cobalt dichloride | increases expression | ISO | RGD:1321245 | 6480464 | cobaltous chloride results in increased expression of FBXO9 mRNA | CTD | PMID:19376846 |
| copper(2+) sulfate | decreases expression | ISO | RGD:1321245 | 6480464 | Copper Sulfate results in decreased expression of FBXO9 mRNA | CTD | PMID:19549813 |
| diazoxide | decreases expression | ISO | RGD:1321246 | 6480464 | Isoproterenol results in decreased expression of FBXO9 mRNA | CTD | PMID:21335049 |
| dibutyl phthalate | decreases expression | ISO | RGD:1321246 | 6480464 | Dibutyl Phthalate results in decreased expression of FBXO9 mRNA | CTD | PMID:17361019 |
| eugenol | decreases expression | ISO | RGD:1321245 | 6480464 | Eugenol results in decreased expression of FBXO9 mRNA | CTD | PMID:17374397 |
| fenofibrate | increases expression | ISO | RGD:1321246 | 6480464 | Fenofibrate results in increased expression of FBXO9 mRNA | CTD | PMID:21318169 |
| folic acid | multiple interactions | ISO | RGD:1321246 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBXO9 gene; more ... | CTD | PMID:20938992 |
| formaldehyde | decreases expression | ISO | RGD:1321245 | 6480464 | Formaldehyde results in decreased expression of FBXO9 mRNA | CTD | PMID:20655997 |
| hydrogen peroxide | affects expression | ISO | RGD:1321245 | 6480464 | Hydrogen Peroxide affects the expression of FBXO9 mRNA | CTD | PMID:20044591 |
| isoprenaline | decreases expression | ISO | RGD:1321246 | 6480464 | Isoproterenol results in decreased expression of FBXO9 mRNA | CTD | PMID:21335049 |
| isotretinoin | decreases expression | ISO | RGD:1321245 | 6480464 | Isotretinoin results in decreased expression of FBXO9 mRNA | CTD | PMID:20436886 |
| L-methionine | multiple interactions | ISO | RGD:1321246 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of FBXO9 gene; more ... | CTD | PMID:20938992 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FBXO9 mRNA | CTD | PMID:17602206 |
| nickel sulfate | decreases expression | ISO | RGD:1321245 | 6480464 | nickel sulfate results in decreased expression of FBXO9 mRNA | CTD | PMID:18651567 |
| paracetamol | affects expression | ISO | RGD:1321246 | 6480464 | Acetaminophen affects the expression of FBXO9 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:1321245 | 6480464 | Acetaminophen results in decreased expression of FBXO9 mRNA | CTD | PMID:21420995 |
| phenobarbital | affects expression | ISO | RGD:1321245 | 6480464 | Phenobarbital affects the expression of FBXO9 mRNA | CTD | PMID:19159669 |
| pirinixic acid | decreases expression | ISO | RGD:1321246 | 6480464 | pirinixic acid results in decreased expression of FBXO9 mRNA | CTD | PMID:18445702 |
| piroxicam | multiple interactions | ISO | RGD:1321245 | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in increased expression of FBXO9 mRNA] | CTD | PMID:21858171 |
| piroxicam | increases expression | ISO | RGD:1321245 | 6480464 | Piroxicam results in increased expression of FBXO9 mRNA | CTD | PMID:21858171 |
| silicon dioxide | decreases expression | ISO | RGD:1321246 | 6480464 | Silicon Dioxide results in decreased expression of FBXO9 mRNA | CTD | PMID:19073995 |
| valproic acid | increases expression | ISO | RGD:1321245 | 6480464 | Valproic Acid results in increased expression of FBXO9 mRNA | CTD | PMID:19101580 |
| valproic acid | affects expression | ISO | RGD:1321246 | 6480464 | Valproic Acid affects the expression of FBXO9 mRNA | CTD | PMID:17292431 |